CTI BIOPHARMA CORP Annual Operating Income (Loss) in USD from 2010 to 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Cti Biopharma Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
Cti Biopharma Corp Operating Income (Loss) for the quarter ending March 31, 2023 was -$9.23M, a 73.7% increase year-over-year.
Cti Biopharma Corp Operating Income (Loss) for the twelve months ending March 31, 2023 was -$53.9M, a 52.4% increase year-over-year.
Cti Biopharma Corp annual Operating Income (Loss) for 2022 was -$79.8M, a 16.3% increase from 2021.
Cti Biopharma Corp annual Operating Income (Loss) for 2021 was -$95.3M, a 99.6% decline from 2020.
Cti Biopharma Corp annual Operating Income (Loss) for 2020 was -$47.8M, a 17.3% decline from 2019.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	-$79.8M	+$15.5M	+16.3%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-06
2021	-$95.3M	-$47.6M	-99.6%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-06
2020	-$47.8M	-$7.06M	-17.3%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-31
2019	-$40.7M	-$7.81M	-23.7%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-17
2018	-$32.9M	+$6.62M	+16.8%	Jan 1, 2018	Dec 31, 2018	10-K	2020-03-13
2017	-$39.5M	+$9.64M	+19.6%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-13
2016	-$49.2M	+$67.5M	+57.9%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-07
2015	-$117M	-$30.4M	-35.3%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-07
2014	-$86.2M	-$44.7M	-108%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-02
2013	-$41.5M	+$60M	+59.1%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-17
2012	-$101M	-$39.3M	-63.2%	Jan 1, 2012	Dec 31, 2012	10-K	2015-03-12
2011	-$62.2M	+$16.2M	+20.7%	Jan 1, 2011	Dec 31, 2011	10-K	2014-03-04
2010	-$78.4M			Jan 1, 2010	Dec 31, 2010	10-K	2013-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.